AS1134900

• CAT Number: I043329
• CAS Number: 149760-98-5
• Molecular Formula: C25H22N8S
• Molecular Weight: 466.56
• Purity: ≥95%
• Synonyms: 6-[(7-methyl-2-propylimidazo[4,5-b]pyridin-4-yl)methyl]-2-[2-(2H-tetrazol-5-yl)phenyl]-1,3-benzothiazole
• InChI: InChI=1S/C25H22N8S/c1-3-6-21-27-22-15(2)11-12-33(24(22)28-21)14-16-9-10-19-20(13-16)34-25(26-19)18-8-5-4-7-17(18)23-29-31-32-30-23/h4-5,7-13H,3,6,14H2,1-2H3,(H,29,30,31,32)
• InChIKey: LGDMZWWVVLGYPR-UHFFFAOYSA-N
• SMILES: CCCC1=NC2=C(C=CN(C2=N1)CC3=CC4=C(C=C3)N=C(S4)C5=CC=CC=C5C6=NNN=N6)C

AS1134900（Cat No.:I043329）is an investigational compound being studied for its potential therapeutic applications, particularly in cancer treatment. It is a small molecule inhibitor that targets specific signaling pathways involved in tumor growth and survival. AS1134900 works by inhibiting key kinases or proteins that play a role in cell proliferation, angiogenesis, and metastasis. Research is ongoing to evaluate its efficacy, safety, and potential to treat various cancers, including solid tumors and hematological malignancies. If successful, AS1134900 could offer a promising new treatment option for patients with resistant or advanced cancers.